More Medical Articles


Leading the hunt for a COVID-19 vaccine

Andrew Stone, (Apr 1, 2020)

J&J gives the inside track on the search for a COVID-19 vaccine at eyeforpharma’s Barcelona conference

Medical: Pharma’s New North Star

Tom Disley, (Feb 20, 2020)

Already growing in importance, Medical Affairs will become a key differentiator for pharma campanies prepared to adapt and invest in the function
Access and Evidence

Into pharma's roaring twenties

Paul Simms, (Jan 14, 2020)

A new decade is here. And despite the incredible science, pharma is ill-equipped.

Invest in MSLs to reap bigger gains

Andrew Stone, (Dec 31, 2019)

To get the most from MSLs pharma needs to invest, measure and empower
Access and Evidence

Prescription drug pricing: The times they are a changin’

Ulrich Neumann, (Nov 25, 2019)

The political mood in the US on drug pricing at a national and state level is putting the pressure on pharma to demonstrate value

Taking the plunge into digital

Andrew Stone, (Nov 13, 2019)

Medical affairs is starting to expand its knowledge, reach and engagement with digital tools

Putting Major Depressive Disorder On The Map

Adam Chapman, (May 24, 2019)

A MDD educational programme from Takeda and Medscape scoops the most valuable HCP Initiative Award

Future Perfect

Hugh Gosling, (Apr 5, 2018)

Future-proofing your business is about big data and advanced analytics, not crystal balls and guesswork, says UCB Chief Marketing Officer, Bharat Tewarie

Medical Affairs Disrupted

Deirdre Coleman, (Mar 16, 2017)

How do we optimize medical affairs to engage patients, understand their needs and create patient-centric medical information exchange

Boosting Medical’s Role in Early Development

Deirdre Coleman, (Mar 10, 2017)

Pharma may be missing an opportunity by not involving Medical Affairs in early stage development